SingerM, DeutschmanCS, SeymourCW, et al.The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 2016; 315(8):801–810; doi: 10.1001/jama.2016.0287
2.
DantesRB, EpsteinL. Combatting sepsis: A public health perspective. Clin Infect Dis, 2018; 67(8):1300–1302; doi: 10.1093/cid/ciy342
3.
KaulDR, FlandersSA, BeckJM, et al.Incidence, etiology, risk factors, and outcome of hospital-acquired fever. J Gen Intern Med, 2006; 21(11):1184–1187; doi: 10.1111/j.1525-1497.2006.00566.x
4.
YoungPJ, SaxenaM, BeasleyR, et al.Early peak temperature and mortality in critically ill patients with or without infection. Intensive Care Med, 2012; 38:437–444; doi: 10.1007/s00134-012-2478-3
5.
TofanV, LenghelA, de CamargoMM, et al.Fever as an evolutionary agent to select immune complexes interfaces. Immunogenetics, 2022; 74(5):465–474; doi: 10.1007/s00251-022-01263-8
6.
LeeBH, InuiD, SuhGY, et al.Association of body temperature and antipyretic treatments with mortality of critically ill patients with and without sepsis: Multi-centered prospective observational study. Crit Care, 2012; 16(1):R33; doi: 10.1186/cc11211
7.
UmarD, DasA, GuptaS, et al.Febrile temperature change modulates CD4 T cell differentiation via a TRPV channel-regulated Notch-dependent pathway. Proc Natl Acad Sci USA, 2020; 117(36):22357–22366; doi: 10.1073/pnas.1922683117
8.
DrewryAM, MohrNM, AblordeppeyEA, et al.Therapeutic hyperthermia is associated with improved survival in afebrile critically ill patients with sepsis: A pilot randomized trial. Crit Care Med, 2022; 50(6):924–934; doi: 10.1097/CCM.0000000000005470
9.
WassermanDD, CreechJA, HealyM. Cooling Techniques for Hyperthermia. 2021 Oct 20. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–.
10.
SchortgenF. Fever in sepsis. Minerva Anestesiol, 2012; 78(11):1254–1264.
11.
NivenDJ, StelfoxHT, LauplandKB. Antipyretic therapy in febrile critically ill adults: A systematic review and meta-analysis. J Crit Care, 2013; 28(3):303–310; doi: 10.1016/j.jcrc.2012.09.009
12.
DoyleJF, SchortgenF. Should we treat pyrexia? And how do we do it?. Crit Care, 2016; 20(1):303; doi: 10.1186/s13054-016-1467-2
13.
PerryMC, YaegerSK, NoorbakhshK, et al.Hypothermia in young infants: Frequency and yield of sepsis workup. Pediatr Emerg Care, 2021; 37(8):e449–e455; doi: 10.1097/PEC.0000000000001674
14.
BhavaniSV, CareyKA, GilbertER, et al.Identifying novel sepsis subphenotypes using temperature trajectories. Am J Respir Crit Care Med, 2019; 200(3):327–335; doi: 10.1164/rccm.201806-1197OC
15.
StanRC, FrançosoKS, AlvesRPS, et al.Febrile temperatures increase in vitro antibody affinity for malarial and dengue antigens. PLoS Negl Trop Dis, 2019; 13(4):e0007239; doi: 10.1371/journal.pntd.0007239
16.
MaceTA, ZhongL, KilpatrickC, et al.Differentiation of CD8+ T cells into effector cells is enhanced by physiological range hyperthermia. J Leukoc Biol, 2011; 90(5):951–962; doi: 10.1189/jlb.0511229
17.
LeeCT, ZhongL, MaceTA, RepaskyEA. Elevation in body temperature to fever range enhances and prolongs subsequent responsiveness of macrophages to endotoxin challenge. PLoS One, 2012; 7(1):e30077; doi: 10.1371/journal.pone.0030077
